Team
At Nemdx, we find purpose in our mission and call on our passion as we contribute to the efforts of industry and academia to tackle a few of the most important healthcare problems in the world. Each person at Nemdx plays a vital role in navigating the complexity of our endeavor, and we continuously collaborate because we believe we can each contribute in solving global healthcare problems.
Vito Levi D’Ancona
Executive Chairman
- Scientific Venture Partners
- Qbiotix
- Solus (Perkin Elmer)
- Phasor (Hanwha)
- Microtest (LumiraDx)
Dr Ian Thrippleton
Chief Technical Officer
- Qbiotix
- Miacom Dx (Metasystems-Indigo)
- Difco Laboratories (Beckton Dickinson)
- Instrumentation Laboratory
- Max Planck Institute
Dr Dalia Cohen
Chief Scientific Officer
- Outcome Capital, Beryllium
- Asterand, Rosetta Genomics
- Novartis (VP Global Head – Functional Genomics)
Dr Zafrira Avnur
Director
- Quark Ventures
- Roche (Global head of Academic Innovation)
Hillel Bachrach
Director
- 2020 Healthcare Partners
- UltraSPECT (Pharmalogic)
- Corindus (Siemens).
- Orex (Kodak)
- Variantyx Molecular genomics Dx
Diagnosis & Decisions through Innovative New Technologies and Assays
Nemdx is dedicated to accelerating patient diagnosis and enabling swift therapeutic decisions through innovative new technologies and assays.